Skip directly to content

Pfizer update on the Competition Appeal Tribunal

07/06/18

 

We are pleased that the Competition Appeal Tribunal has overturned the Competition and Markets Authority's finding that Pfizer abused its dominant position – along with the associated fine. Our priority has always been to ensure a sustainable supply of our medicines to UK patients and this was at the heart of our decision to divest this medicine.